Evidence map›Paper›PMID 36875440›Full record

ArticleChinese herbal medicines2023

Aruna Qian, Lu Zhou, Dongxu Shi, Zongran Pang, Binan Lu

Open access · goldAbstract read
In one paragraph

Article in Chinese herbal medicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Polysaccharides from the Cherry Peel ofFoods (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Effect ofChinese herbal medicines · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Phytochemical Characteristics and Anti-Inflammatory, Immunoregulatory, and Antioxidant Effects ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aruna QianSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Lu ZhouSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Dongxu ShiSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Zongran PangSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Binan LuSchool of Pharmacy, Minzu University of China, Beijing 100081, China.
Minzu University of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Acute liver injury (ALF) is a potential factor of many serious hepatopathies. Carbon tetrachloride (CCl Methods: The effect of PO on ALF was evaluated by CCl Results: Animal tests showed that pretreatment with PO reduced the liver pathological tissue damage and the serum levels of ALT, AST, ALT and LDH, as well as reducing the pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) secretion in CCl Conclusion: PO may down-regulate S100A8 and S100A9 and inhibit pro-inflammatory cytokines' release, indicating a potential clinical effect for controlling the disease.

Indexed as

acute liver injuryCCl4Portulaca oleracea L.S100A8S100A9

Identifiers

PMID36875440
PMCPMC9975634
OpenAlexW4291221772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.